News

Search:

As User Fee Bill Sails Through House Committee Vote, a Focus on Industry Efforts

0 Likes

The House Energy and Commerce Committee advanced the Food and Drug Administration (FDA) Reform Act of 2012, a package of proposals to both fund and reform the agency, by a unanimous vote involving 46 Read More...

Tags:

Bill

BIPUFA

BsUFA

Congress

drug

FDA

GDUFA

House

Industry

Legislation

Lobbying

MDUFA

Medical Device

PDUFA

Pharmaceutical

PhRMA

Senate

User Fees

Group: Industry Lobbying Tarnishing FDA Integrity

0 Likes

The science advocacy group Union of Concerned Scientists (USC) is lambasting what it claims is excessive industry pressure on the US Food and Drug Administration (FDA), and claims the pharmaceutical, Read More...

Tags:

Congress

Executive

FDA

Integrity

Lobbying

Lobbyist

Science

Union of Concerned Scientists

USC

White House

Washington Lobby Groups Fight Attempt to Limit Chimpanzee Research

0 Likes

Washington-based lobbyists are launching a counteroffensive against a piece of proposed legislation known as the Great Ape Protection and Cost Savings Act that would ban researchers that use Read More...

Tags:

Bill

Chimpanzees

Congress

Great Ape

House

Legislation

Lobbying

Lobbyists

Nonclinical Trial

Research

Senate

RF Today is Regulatory Focus' daily news brief. Each edition contains the top global regulatory news stories about pharmaceuticals, medical devices, biotechnology and more. Learn more

Most Viewed
Most Popular

Most Viewed

FDA Plans Huge Cardiovascular Registry With Focus on Medical Devices 2 April 2013
In Unprecedented Shift, EU Parliament Proposes Premarket Authorization for Medical Devices 15 April 2013
Goodbye, KFDA: Korean Regulator Gets New Name, Decentralized Authority After Reorganization 28 March 2013
FDA Gets Go-Ahead for Study of DTC Advertising and Social Media 18 April 2013
UPDATED: President's Budget Proposal Calls for Small Increases at FDA, but Big Changes for Industry 11 April 2013
IBM Awarded Huge Contract to Modernize Regulatory Review Processes at FDA 29 April 2013
New FDA Document Clarifies IND Process for Drugs, Biologics and Biosimilars 30 April 2013
Warning Letter to Company Cites Low Supplies of Toilet Paper 15 May 2013

New Regulatory Focus Apps for iPad and iPhone

Stay Connected:

Regulatory Focus is for regulatory professionals written by regulatory professionals.

The publication takes a look at the important topics facing regulatory professionals in a changing global healthcare landscape. From topics ranging from research and development to labeling and marketing, the articles try to analyze, inform, and educate readers about the issues at the forefront of the industry.

Rated as the number one benefit by the members of RAPS, Regulatory Focus strives to provide the best and most current information to regulatory professionals so they can succeed and advance at every stage in their careers.

For questions or comments on our content or to find out more about Regulatory Focus, please visit our About RF page.

News

As User Fee Bill Sails Through House Committee Vote, a Focus on Industry Efforts

Group: Industry Lobbying Tarnishing FDA Integrity

Washington Lobby Groups Fight Attempt to Limit Chimpanzee Research

Get RF Today